phenylephrine has been researched along with isradipine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Andersson, OK; Bagge, U; Persson, B; Wysocki, M | 1 |
| Brisac, AM; Lacolley, P; Laurent, S; Legrand, M; Schmitt, H; Tsoucaris-Kupfer, D | 1 |
| Berthold, H; Fozard, JR; Mir, AK; Scholtysik, GE | 1 |
| Eglen, RM; Michel, AD; Sharif, NA; Swank, SR; Whiting, RL | 1 |
| Barrès, C; Cerutti, C; Morin, B; Sassard, J | 1 |
| Hof, A; Hof, RP | 1 |
| Ishiguro, S; Miyamoto, A; Nishio, A; Sakaguchi, H | 1 |
| Nishio, A; Sakaguchi, H | 1 |
| Chamiot-Clerc, P; Copie, X; Girerd, X; Renaud, JF; Safar, M | 1 |
| Guimarães, S; Nunes, JP | 1 |
| Addonizio, VP; Brister, NW; Carlsson, C; Chen, D; Cooper, SC; Harakal, C; Krasner, LJ; Wendling, WW | 1 |
1 trial(s) available for phenylephrine and isradipine
| Article | Year |
|---|---|
Flow resistance and its components in hypertensive men treated with the calcium antagonist isradipine.
Topics: Adult; Aged; Arteries; Blood Pressure; Compliance; Hemodynamics; Humans; Hypertension; Isradipine; Male; Middle Aged; Phenylephrine; Rheology; Vascular Resistance; Veins | 1992 |
12 other study(ies) available for phenylephrine and isradipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Central modulation of baroreceptor reflex response to phenylephrine by dihydropyridines in rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atropine Derivatives; Blood Pressure; Brain; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Isradipine; Male; Muscarine; Oxadiazoles; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Reflex | 1988 |
Cardiovascular effects of endothelin 1 in pithed spontaneously hypertensive rats: evaluation of its mechanism(s) of action.
Topics: Angiotensin II; Animals; Coronary Circulation; Decerebrate State; Dose-Response Relationship, Drug; Electrocardiography; Endothelins; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Isradipine; Male; Peptides; Phenylephrine; Pyridines; Rats; Rats, Inbred SHR | 1989 |
The pharmacological properties of the peptide, endothelin.
Topics: Animals; Blood Pressure; Calcium Channels; Carbachol; Cerebral Cortex; Endothelins; Female; Guinea Pigs; In Vitro Techniques; Isoproterenol; Isradipine; Male; Mollusk Venoms; Muscle Contraction; Muscle, Smooth, Vascular; Muscles; omega-Conotoxin GVIA; Oxadiazoles; Peptides; Phenylephrine; Potassium Chloride; Rabbits; Rats; Rats, Inbred Strains | 1989 |
Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Isradipine; Male; Nifedipine; Nitroglycerin; Oxadiazoles; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Reflex | 1988 |
Vasoconstrictor and vasodilator effects in normal and atherosclerotic conscious rabbits.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; In Vitro Techniques; Isradipine; Norepinephrine; Phenylephrine; Pyridines; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 1988 |
Enhanced contractile response to phenylephrine and increased density of [3H]PN200-110 binding sites in thoracic aorta isolated from dietary magnesium-deficient rats.
Topics: Animals; Aorta, Thoracic; Calcium Channels; Diet; Endothelium, Vascular; Isradipine; Magnesium Deficiency; Male; Muscle Contraction; Nifedipine; Phenylephrine; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1 | 1994 |
Mechanisms of the enhanced contractile response to phenylephrine in thoracic aorta isolated from rats with dietary magnesium deficiency.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aorta, Thoracic; Diet; In Vitro Techniques; Isoquinolines; Isradipine; Magnesium Deficiency; Male; Nifedipine; Phenylephrine; Piperazines; Potassium Chloride; Rats; Rats, Wistar; Vasoconstriction | 1994 |
Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries.
Topics: Biomechanical Phenomena; Calcium Channel Blockers; Coronary Artery Bypass; Elasticity; Humans; In Vitro Techniques; Isradipine; Mammary Arteries; Middle Aged; Nitroprusside; Norepinephrine; Phenylephrine; Potassium Chloride; Radial Artery; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
The influence of the wall tension on the contractile responses of arteries.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Aorta, Thoracic; Arteries; Endothelium, Vascular; Enzyme Inhibitors; Gadolinium; In Vitro Techniques; Isradipine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Protein Kinase C; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Effects of stretch or distention on phenylephrine-induced constriction of human coronary artery bypass grafts.
Topics: Coronary Artery Bypass; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Isradipine; Mammary Arteries; Phenylephrine; Potassium; Saphenous Vein; Stress, Mechanical; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2001 |